ArticleAntibiotics (Basel, Switzerland)2026
Synovial Calprotectin in Suspected Periprosthetic Joint Infection After Total Knee Arthroplasty: Diagnostic Accuracy and Exploratory Adjunctive Value to Preoperative ICM Classification.
Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesDiagnosis of periprosthetic joint infection (PJI) after total knee arthroplasty remains challenging when standard criteria are inconclusive. This study evaluated the diagnostic accuracy of synovial calprotectin and its prespecified exploratory adjunctive value to preoperative 2018 International Consensus Meeting (ICM) classification.
methodsThis prospective single-center diagnostic accuracy study included 35 consecutive patients with primary or revision total knee arthroplasty who underwent synovial calprotectin testing followed by surgery for suspected PJI. Calprotectin was measured using a lateral flow assay with a prespecified threshold of ≥50 mg/L. Diagnostic performance was assessed against a multidisciplinary composite postoperative reference standard that did not incorporate calprotectin.
resultsTwenty-one patients were classified as infected and 14 as non-infected. Calprotectin yielded 18 true-positive, 11 true-negative, 3 false-positive, and 3 false-negative results, corresponding to 85.7% sensitivity, 78.6% specificity, 85.7% positive predictive value, 78.6% negative predictive value, and an area under the curve of 0.83. Preoperative ICM correctly classified 26 patients, misclassified one, and left eight inconclusive. Among the inconclusive cases, calprotectin correctly classified all six non-infected patients but neither of the two infected patients. The combined strategy classified all 35 patients, correctly classifying 32 and misclassifying three. Among 10 antibiotic-exposed patients-seven infected and three non-infected-no misclassifications occurred; this finding was descriptive.
conclusionsSynovial calprotectin showed good overall diagnostic performance in this surgically managed cohort. When applied to preoperative ICM-inconclusive cases, it increased classification yield but missed both infected cases and should not be used alone to exclude PJI. Larger blinded multicenter studies are required before routine implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.